[Form 4] CeriBell, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ceribell, Inc. insider sale disclosed. David Foehr, Senior VP, Finance and PAO and a company officer, sold 484 shares of Ceribell common stock on 08/25/2025 at $11.58 per share. After the sale he beneficially owns 21,116 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025, documenting the transaction and reporting compliance.

Positive

• Disclosure compliance: The Form 4 reports the insider sale and post-transaction ownership, meeting Section 16 reporting requirements.
• Timely signature: Document includes signature by attorney-in-fact dated 08/27/2025, indicating formal execution of the filing.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine officer sale disclosed; no indication of disciplinary, governance, or material corporate change.

The Form 4 shows an officer-level insider sale of 484 shares at $11.58, leaving 21,116 shares beneficially owned. The filing appears procedural and timely, executed via attorney-in-fact. There is no accompanying information about reasons for the sale, any related plan, or additional transactions. From a governance perspective this is a standard disclosure fulfilling Section 16 reporting obligations.

Securities Analyst

TL;DR: Small volume insider sale; not clearly material to company valuation or operations.

The transaction size (484 shares) is small relative to typical outstanding shares and the filing records a per-share price of $11.58. The report provides required transparency for insider activity but lacks context such as whether the sale was part of a Rule 10b5-1 plan. There is no earnings, financing, or other market-moving detail included.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foehr David

(Last) (First) (Middle)

C/O CERIBELL, INC.

360 N. PASTORIA AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP, Finance and PAO

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		F		484	D	$11.58	21,116	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Louisa Daniels, Attorney-in-Fact for David Foehr	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Ceribell (CBLL) Form 4 filed for David Foehr disclose?

The Form 4 shows that David Foehr sold 484 shares of Ceribell common stock on 08/25/2025 at $11.58 per share and now beneficially owns 21,116 shares.

What position does the reporting person hold at Ceribell (CBLL)?

The reporting person, David Foehr, is listed as an officer with the title Senior VP, Finance and PAO and is identified as an officer on the Form 4.

Is the Form 4 filing for the CBLL transaction signed and dated?

Yes. The form includes a signature by Louisa Daniels, Attorney-in-Fact for David Foehr dated 08/27/2025.

Was the sale part of a Rule 10b5-1 plan according to the filing?

The filing does not state that the transaction was made pursuant to a Rule 10b5-1 plan; no affirmative defense or plan notation is provided in the content.

How much did the insider receive per share in the reported sale?

The reported sale price was $11.58 per share for the 484 shares sold on 08/25/2025.